• Теги
    • избранные теги
    • Компании925
      • Показать ещё
      Разное251
      • Показать ещё
      Международные организации9
      • Показать ещё
      Страны / Регионы148
      • Показать ещё
      Показатели26
      • Показать ещё
      Люди27
      • Показать ещё
      Издания4
      Формат1
      Сферы1
Vertex Pharmaceuticals
31 июля, 08:23

Chopping Through the Amazon Report

Chopping Through the Amazon Report

27 июля, 17:42

Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK

Total earnings for these 171 index members were up 8.8% from the year-ago quarter on a 3.4% improvement in revenues. Let's see how things are shaping up for the announcements.

27 июля, 16:54

Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms

Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms

27 июля, 15:59

Vertex (VRTX) Q2 Earnings Top on Solid Cystic Fibrosis Sales

Vertex Pharmaceuticals Incorporated's (VRTX) Q2 results were encouraging, as it topped earnings and revenues expectations backed by higher sales of both its CF drugs.

Выбор редакции
26 июля, 15:34

5 Top Efficient Stocks to Buy for a Winning Portfolio

Efficiency, the ability to transform inputs into outputs, is a potential indicator of a company's financial health.

25 июля, 23:01

Top Stock Picks for the Week of July 24th

A Couple of Healthy Companies to Consider.

25 июля, 18:18

Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK

We have three pharma giants that are set to report second-quarter results on Jul 26. Let's see how things are shaping up for this quarter.

25 июля, 17:57

What's in the Cards for Geron (GERN) this Earnings Season?

Investors will be looking at Geron's progress with its hematologic myeloid malignancies pipeline candidate, Imetelstat.

25 июля, 17:42

Can Intercept (ICPT) Beat Estimates this Earnings Season?

Intercept Pharmaceuticals, Inc.'s (ICPT) lead drug Ocaliva's uptake has been encouraging and we expect the company to throw light on its label expansion when it reports second-quarter results.

25 июля, 16:42

Will Radius Health (RDUS) Disappoint this Earnings Season?

Radius Health Inc. (RDUS) is expected to throw light on the launch and uptake of its newly approved drug Tymlos when it reports second-quarter results.

25 июля, 16:23

Gigamon (GIMO) to Report Q2 Earnings: What's in the Cards?

We expect fiscal second-quarter earnings of Gigamon (GIMO) to gain traction from product launches.

25 июля, 15:55

Xilinx (XLNX) to Post Q1 Earnings: What's in the Cards?

Xilinx's (XLNX) growing demand for 28-nm, 20-nm and 16-nm nodes is likely fuel Q1 Earnings. The company's product launches should further aid revenues.

25 июля, 15:47

Why Vertex Pharmaceuticals (VRTX) Might Surprise This Earnings Season

Vertex Pharmaceuticals (VRTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

25 июля, 01:40

Biotech ETF Industry Outlook for Second Half 2017

There are several reasons to be positive on biotech stocks and ETFs for the rest of the year.

24 июля, 17:44

What's in the Cards for Exelixis (EXEL) in Q2 Earnings?

Exelixis, Inc.'s (EXEL) efforts to develop its pipeline and uptake in Cabometyx sales should be the key areas of focus when the company reports second-quarter results.

24 июля, 17:25

Is Celgene (CELG) Poised For a Beat This Earnings Season?

Celgene Corporation (CELG) is likely to beat on earnings estimates when it reports results on July 27 on the back of growth in Revlimid driven by share gains in important markets.

24 июля, 17:18

Top Ranked Momentum Stocks to Buy for July 24th

Top Ranked Momentum Stocks to Buy for July 24th

24 июля, 15:36

Equifax (EFX) to Post Q2 Earnings: What's in the Cards?

Equifax's (EFX) strategic initiatives for product innovation, acquisitions and continuous share gains in North America, are likely to act as tailwinds in Q2.

24 июля, 15:34

What's in the Offing for F5 Networks (FFIV) in Q3 Earnings?

F5 Networks Inc.'s (FFIV) GBB pricing strategy and its BIG-IQ platform will remain tailwinds in Q3.

21 июля, 21:46

Is a Beat in the Cards for Vertex (VRTX) in Q2 Earnings?

Impressive performance of Vertex Pharmaceuticals' (VRTX) cystic fibrosis drugs Kalydeco and Orkambi may drive the stock to an earnings beat in Q2.